Free Trial

Synthomer (LON:SYNT) Trading Up 15.4% - Time to Buy?

Synthomer logo with Basic Materials background
Image from MarketBeat Media, LLC.

Key Points

  • Synthomer shares jumped 15.4% on Wednesday to around GBX 52 (intraday high GBX 52.60) while traded volume (~725,470 shares) was about 56% below the daily average.
  • Analyst sentiment is muted: Deutsche Bank cut its price target to GBX 62 and set a "hold," and the consensus rating is "Hold" with an average target of GBX 90.50.
  • Fundamentals show a small market cap (£82.06m), a negative P/E (-0.98) and high leverage (debt-to-equity ~97.65), indicating earnings weakness and balance-sheet risk despite the recent rally.
  • Five stocks we like better than Synthomer.

Synthomer plc (LON:SYNT - Get Free Report)'s stock price was up 15.4% on Wednesday . The company traded as high as GBX 52.60 and last traded at GBX 52.04. Approximately 725,470 shares changed hands during trading, a decline of 56% from the average daily volume of 1,667,707 shares. The stock had previously closed at GBX 45.10.

Wall Street Analyst Weigh In

Separately, Deutsche Bank Aktiengesellschaft reduced their price objective on shares of Synthomer from GBX 96 to GBX 62 and set a "hold" rating for the company in a research note on Monday, February 2nd. Four investment analysts have rated the stock with a Hold rating, Based on data from MarketBeat, the company currently has an average rating of "Hold" and a consensus target price of GBX 90.50.

Read Our Latest Report on Synthomer

Synthomer Stock Performance

The firm has a market capitalization of £82.06 million, a P/E ratio of -0.98, a price-to-earnings-growth ratio of -0.17 and a beta of 0.57. The company has a current ratio of 1.64, a quick ratio of 0.97 and a debt-to-equity ratio of 97.65. The business's 50 day simple moving average is GBX 32.18 and its two-hundred day simple moving average is GBX 47.27.

About Synthomer

(Get Free Report)

Synthomer plc is a leading supplier of high-performance, highly specialised polymers and ingredients that play vital roles in key sectors such as coatings, construction, adhesives, and health and protection – growing markets for customers who serve billions of end users worldwide. Headquartered in London, UK and listed on the LSE since 1971, we employ c.3,800 employees across our five innovation centres of excellence and 29 manufacturing sites across Europe, North America, Middle East and Asia.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Synthomer Right Now?

Before you consider Synthomer, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synthomer wasn't on the list.

While Synthomer currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 7 Hottest IPOs On Wall Street’s 2026 Watchlist Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines